Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol
- 1 February 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 33 (3) , 297-304
- https://doi.org/10.1016/0049-3848(84)90165-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Congenital Protein C Deficiency and Venous ThromboembolismNew England Journal of Medicine, 1983
- EFFECT OF STANOZOLOL ON ANTITHROMBIN III AND PROTEIN CThe Lancet, 1983
- DEFICIENCIES OF PROTEIN C, AN INHIBITOR OF BLOOD COAGULATIONThe Lancet, 1982
- PREDICTION AND SELECTIVE PROPHYLAXIS OF VENOUS THROMBOSIS IN ELECTIVE GASTROINTESTINAL SURGERYThe Lancet, 1982
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981
- Generation of fibrinolytic activity by infusion of activated protein C into dogs.Journal of Clinical Investigation, 1981
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980
- Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression.BMJ, 1980
- A Genetic Variant of Factor IX with Decreased Capacity for Ca2+ BindingBritish Journal of Haematology, 1979
- Treatment of Raynaud's phenomenon by fibrinolytic enhancement.BMJ, 1978